These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 17597457)
1. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus. Liu WL; Su WC; Cheng CW; Hwang LH; Wang CC; Chen HL; Chen DS; Lai MY J Infect Dis; 2007 Aug; 196(3):425-34. PubMed ID: 17597457 [TBL] [Abstract][Full Text] [Related]
2. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment. Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259 [TBL] [Abstract][Full Text] [Related]
3. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8. Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy. Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus expression and interferon antiviral action is dependent on PKR expression. Tokumoto Y; Hiasa Y; Horiike N; Michitaka K; Matsuura B; Chung RT; Onji M J Med Virol; 2007 Aug; 79(8):1120-7. PubMed ID: 17596833 [TBL] [Abstract][Full Text] [Related]
6. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. Taylor DR; Puig M; Darnell ME; Mihalik K; Feinstone SM J Virol; 2005 May; 79(10):6291-8. PubMed ID: 15858013 [TBL] [Abstract][Full Text] [Related]
7. [Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon]. Jia YT; Wei L; Jiang D; Cong X; Fei R Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2065-9. PubMed ID: 16313804 [TBL] [Abstract][Full Text] [Related]
8. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes. Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316 [TBL] [Abstract][Full Text] [Related]
9. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Helbig KJ; Ruszkiewicz A; Semendric L; Harley HA; McColl SR; Beard MR Hepatology; 2004 May; 39(5):1220-9. PubMed ID: 15122750 [TBL] [Abstract][Full Text] [Related]
10. Combination of a hepatitis C virus NS3-NS4A protease inhibitor and alpha interferon synergistically inhibits viral RNA replication and facilitates viral RNA clearance in replicon cells. Lin K; Kwong AD; Lin C Antimicrob Agents Chemother; 2004 Dec; 48(12):4784-92. PubMed ID: 15561857 [TBL] [Abstract][Full Text] [Related]
11. Lack of clinical evidence for involvement of hepatitis C virus interferon-alpha sensitivity-determining region variability in RNA-dependent protein kinase-mediated cellular antiviral responses. Mihm S; Monazahian M; Grethe S; Meier V; Thomssen R; Ramadori G J Med Virol; 2000 May; 61(1):29-36. PubMed ID: 10745229 [TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha and ribavirin resistance of Huh7 cells transfected with HCV subgenomic replicon. Aus dem Siepen M; Oniangue-Ndza C; Wiese M; Ross S; Roggendorf M; Viazov S Virus Res; 2007 Apr; 125(1):109-13. PubMed ID: 17254660 [TBL] [Abstract][Full Text] [Related]
13. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway. Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system. Mori K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N Virus Res; 2011 Apr; 157(1):61-70. PubMed ID: 21320556 [TBL] [Abstract][Full Text] [Related]
15. Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection. Miyatake H; Kanto T; Inoue M; Sakakibara M; Kaimori A; Yakushijin T; Itose I; Miyazaki M; Kuzushita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N J Viral Hepat; 2007 Jun; 14(6):404-12. PubMed ID: 17501761 [TBL] [Abstract][Full Text] [Related]
16. PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control. Kang JI; Kwon SN; Park SH; Kim YK; Choi SY; Kim JP; Ahn BY Virus Res; 2009 Jun; 142(1-2):51-6. PubMed ID: 19189853 [TBL] [Abstract][Full Text] [Related]
17. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400 [TBL] [Abstract][Full Text] [Related]
18. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus. Rigopoulou EI; Abbott WG; Williams R; Naoumov NV Antiviral Res; 2007 Jul; 75(1):36-42. PubMed ID: 17210188 [TBL] [Abstract][Full Text] [Related]
19. Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathway. Liu WL; Yang HC; Su WC; Wang CC; Chen HL; Wang HY; Huang WH; Chen DS; Lai MY PLoS One; 2012; 7(9):e43824. PubMed ID: 22962590 [TBL] [Abstract][Full Text] [Related]
20. [The direct antiviral effect of interferon-gamma on hepatitis C virus replicon]. Jia YT; Wei L; Jiang D; Cong X; Fei R Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):7-10. PubMed ID: 16420756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]